Delivery Order SPE2DB20D2014-SPE2DB25FC62Y
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract valued at $2,458.96. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.00 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency has awarded a delivery order valued at $2,401.31 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by June 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count supply) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,540.96 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on September 16, 2025, with completion scheduled for September 17, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $1,672.35 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of July 11, 2025, and represents a non-competitive set-aside award. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count) under a firm fixed-price contract valued at $2,843.06, with a completion date of June 3, 2025. This non-set-aside award was competitively issued and reflects the continuation of pharmaceutical procurement through established federal contract vehicles. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,476.51 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on September 15, 2025, with a completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,572.46 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order falls under the...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC62YDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,566.44 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract. The delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award utilizes no set-aside designation and was competitively awarded. This delivery order is issued under AmerisourceBergen Drug Corp's $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position as a critical vendor for federal medical procurement and supplies an extensive portfolio of pharmaceutical products and medical supplies to support Defense Health Agency and other government healthcare systems. The company's contract awards demonstrate consistent capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/1/25 |